Drug intelligence / Profile preview

triptoquinone B

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Triptoquinone B is a bioactive diterpene quinone isolated from the roots of the medicinal plant *Tripterygium wilfordii* Hook f. (Thunder God Vine). It is a key constituent of *Tripterygium wilfordii* polyglycoside tablets (TGTs), which are used in traditional Chinese medicine for their potent anti-inflammatory and immunosuppressive properties. Research indicates that triptoquinone B may have therapeutic potential for treating systemic lupus erythematosus (SLE), particularly in managing associated bone and joint complications. Its mechanism of action involves the regulation of the NLRC3 (NLR family CARD domain containing 3) axis; specifically, it has been shown to diminish NLRC3 expression in chondrocytes. This downregulation leads to a decrease in the production of pro-inflammatory cytokines and the expression of enzymes responsible for cartilage degradation. Additionally, triptoquinone B exhibits antioxidant attributes that contribute to its protective effects against oxidative stress-induced damage in autoimmune conditions.

02

Targets

NLRC3 (NLR family CARD domain-containing protein 3)

Beyond the preview

Go deeper on triptoquinone B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on triptoquinone B.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call